Keyword Connections

influenza

Journals

24

1 Heliyon

2 zhonghua liu xing bing xue za zhi = zhonghua liuxingbingxue zazhi

3 eLife

4 BMC infectious diseases

5 Journal of Asian natural products research

6 gesundheitswesen (bundesverband der arzte des offentlichen gesundheitsdienstes (germany))

7 human vaccines & immunotherapeutics

8 Indian journal of pediatrics

9 nucleosides, nucleotides & nucleic acids

10 health security

11 clinical immunology (orlando, fla)

12 value in health : the journal of the international society for pharmacoeconomics and outcomes research

13 international journal of nursing studies

14 journal of clinical anesthesia

15 proceedings biological sciences

16 Digital health

17 Vaccine

18 journal of the american association of nurse practitioners

19 american journal of obstetrics and gynecology

20 frontiers in neurology

21 Preventive medicine reports

22 the journal of law, medicine & ethics : a journal of the american society of law, medicine & ethics

23 journal of infection and chemotherapy : official journal of the japan society of chemotherapy

24 influenza and other respiratory viruses

Research Groups

0

No Research Group Connected

Bibliographies

519

1 STEM: An Open Source Tool for Disease Modeling.

2 Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia.

3 Health Equity, School Discipline Reform, and Restorative Justice.

4 Are social inequalities in influenza vaccination coverage in Japan reduced by health policy?

5 Synthesis and anti-H5N1 virus activity of triazole- and oxadiazole-pyrimidine hybrids and their nucleoside analogs.

6 Effects of temperature, humidity, and diurnal temperature range on influenza incidence in a temperate region.

7 Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study.

8 The effects of age on clinical characteristics, hospitalization and mortality of patients with influenza-related illness at a tertiary care centre in Malaysia.

9 Corrigendum to "Impact of the cognitive learning factors on sustainable organizational development" [Heliyon Volume 5, Issue 9, September 2019, e02398].

11 Pharmacists' impact on older adults' access to vaccines in the United States.

12 Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain.

13 Partnering with parents to remove barriers and improve influenza immunization rates for young children.

14 Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults.

15 Doctor YouTube's opinion on seasonal influenza: A critical appraisal of the information available to patients.

16 Predicting the short-term success of human influenza virus variants with machine learning.

17 Airway management and ventilation principles in COVID-19 patients.

18 Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 – 2016

19 molecular characterization of severe and mild cases of influenza a (h1n1) 2009 strain from argentina caracterización molecular de cepas de influenza a (h1n1) 2009 de casos leves y graves de la argentina

20 the impact of altitude on hospitalization and hospital mortality from pandemic 2009 influenza a (h1n1) virus pneumonia in mexico el impacto de la altitud en las tasas de hospitalización y mortalidad por el virus de la influenza a (h1n1) pandémico en méxico

21 intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza

22 reacciones adversas a la vacuna contra influenza a (h1n1) en trabajadores de salud de una institución pública peruana

23 perfil epidemiológico de la mortalidad por influenza humana a (h1n1) en méxico epidemiological profile of mortality due to human influenza a (h1n1) in mexico

24 intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus

25 pandemic influenza vaccines – the challenges

26 in vivo production of monoclonal antibodies by gene transfer via electroporation protects against lethal influenza and ebola infections

27 ankara İli 2017 yılı 40. hafta ile 2018 yılı 20. hafta arasında yapılan sentinel İnfluenza benzeri hastalık (İbh) sürveyansının değerlendirilmesi

28 innate immunity induces the accumulation of lung mast cells during influenza infection

29 dendritic cells in innate and adaptive immune responses against influenza virus

30 encuesta nacional de cobertura de vacunación (influenza, neumococo y tétanos) en adultos mayores de 60 años en méxico national survey of vaccination coverage (influenza, pneumococcus and tetanus) in mexican population of 60 years of age and older

31 pseudotype-based neutralization assays for influenza: a systematic analysis

32 clinical and laboratory description of a series of cases of acute viral myositis

33 estudo sorológico sobre a cepa a/new jersey/8/76 em grupos populacionais brasileiros: nota prévia serologic study of the a/new jersey/8/76 influenza virus in brazilian population groups: communication

34 comparison of porcine airway and intestinal epithelial cell lines for the susceptibility and expression of pattern recognition receptors upon influenza virus infection

35 vacinação contra influenza e pneumococo na insuficiência cardíaca: uma recomendação pouco aplicada vacunación contra influenza y neumococo en la insuficiencia cardíaca: una recomendación poco aplicada influenza and pneumococcal vaccination in heart failure: a little applied recommendation

36 higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections

37 cytokine profiles of severe influenza virus-related complications in children

38 key ethical issues discussed at cdc-sponsored international, regional meetings to explore cultural perspectives and contexts on pandemic influenza preparedness and response

39 segurança, imunogenicidade e eficácia da vacina contra o vírus influenza em crianças safety, immunogenicity and efficacy of influenza vaccine in children

40 literature analysis of radiological studies on tuberculosis

41 viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza a(h7n9) virus in zhejiang, china, 2013

42 characterization and epidemiology of influenza viruses in patients seeking treatment for influenza-like illnesses in rural bangladesh

43 influence of media on seasonal influenza epidemic curves

44 the end of the prohibition era: questions about injustice, effectiveness of laws and legalization of drugs

45 b cells and functional antibody responses to combat influenza

46 clinical advances in viral-vectored influenza vaccines

47 medical image of the week: bronchial clot removal via cryotherapy

48 knowledge, attitudes, and practices regarding pandemic h1n1 influenza among medical and dental residents and fellowships in shiraz, iran

49 association of influenza vaccination and reduced risk of stroke hospitalization among the elderly: a population-based case-control study

50 the application of nhej-crispr/cas9 and cre-lox system in the generation of bivalent duck enteritis virus vaccine against avian influenza virus

51 síndrome de guillain-barré em associação temporal com a vacina influenza a guillain-barré syndrome in temporal association with influenza a vaccine

52 Design, synthesis and biological evaluation of honokiol derivatives as influenza neuraminidase inhibitors.

53 Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season

54 Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome

55 Prolonged lymphopenia and prognoses among inpatients with different respiratory virus infections: A retrospective cohort study.

56 Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories.

57 Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

58 Poultry trading behaviours in Vietnamese live bird markets as risk factors for avian influenza infection in chickens.

59 Pandemic (H1N1) influenza in Diyarbakir, 2009

60 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

61 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

62 Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups

63 Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies

64 Drug resistance in influenza A virus: the epidemiology and management

65 Post-influenza aspergillosis, do not underestimate influenza B

66 Peramivir injection in the treatment of acute influenza: a review of the literature

67 Modeling human influenza infection in the laboratory

68 Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

69 Current management of parainfluenza pneumonitis in immunocompromised patients: a review

70 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

71 Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST)

72 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

73 Influenza A Viral Infection with Septic Shock in Pregnancy

74 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

75 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

76 Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups

77 Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies

78 Drug resistance in influenza A virus: the epidemiology and management

79 Post-influenza aspergillosis, do not underestimate influenza B

80 Peramivir injection in the treatment of acute influenza: a review of the literature

81 Modeling human influenza infection in the laboratory

82 Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

83 Current management of parainfluenza pneumonitis in immunocompromised patients: a review

84 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

85 Isolation and Antibiotic Susceptibility Testing of Haemophilus influenzae from Nasopharynx of Children under Five Years Attending Maternal and Child Health Clinic in Mbarara Regional Referral Hospital

86 Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

87 Analytical performances of the BD Veritor™ System for the detection of respiratory syncytial virus and influenzaviruses A and B when used at bedside in the pediatric emergency department.

88 Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient

89 Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China.

90 Observer-Based Adaptive PI Sliding Mode Control of Developed Uncertain SEIAR Influenza Epidemic Model Considering Dynamic Population.

91 Editorial: Epidemiology of Avian Influenza Viruses.

92 Protection of wetlands as a strategy for reducing the spread of avian influenza from migratory waterfowl.

93 Polygalasaponin F treats mice with pneumonia induced by influenza virus.

94 A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

95 Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.

96 A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.

97 Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay

98 A qualitative study of pandemic influenza preparedness among small and medium-sized businesses in New York City.

99 Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis.

100 CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases

101 Health information technology use and influenza vaccine uptake among US adults.